Skip to main content
SLN logo
SLN
(NASDAQ)
Silence Therapeutics plc
$13.06-- (--)
Loading... - Market loading

Silence Therapeutics (SLN) Stock Price & Financial Analysis

Silence Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$12.10 - $13.11
52-Week High$17.58
52-Week Low$4.19
Open$13.11
Volume1.23M
Average Volume (3M)1.52M
Market Cap616.91M
Shares Outstanding47.24M
Price to Sales (P/S)735.91
Price to Book (P/B)16.04
EV/EBITDA-8.08
Revenue (TTM)838.29K
Net Income (TTM)-59.93M
Free Cash Flow (TTM)-42.31M
EPS (TTM)$-1.27
Profit Margin-7148.81%
Operating Margin-8062.92%
Return on Equity (ROE)-151.84%
Debt to Equity0.00
50-Day MA$12.23
200-Day MA$7.78
52-Week Change176.72%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Silence Therapeutics

What is the current stock price for SLN?

As of the latest trading session, SLN stock trades at $12.46. The 52-week range is $4.19–$17.58, with a day range of $12.10–$13.11.

What is the P/E ratio for SLN?

The P/E ratio (Price-to-Earnings) for SLN is shown in the Key Statistics section. This valuation metric helps compare Silence Therapeutics plc to industry peers.

Does SLN pay dividends?

Silence Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SLN?

Based on 1 analyst, the consensus for SLN is Buy.

What is the market cap of SLN?

Silence Therapeutics's market capitalization is $588.6M, classifying it as a small-cap company. Silence Therapeutics operates in the Healthcare sector within the Biotechnology industry.